PET probes beyond 18F-FDG

被引：3
|
作者：
Lei Jiang [1 ,2 ]
Yingfeng Tu [2 ]
Hongcheng Shi [1 ]
Zhen Cheng [2 ]
机构：
[1] Department of Nuclear Medicine,Zhongshan Hospital,Fudan University
[2] Molecular Imaging Program at Stanford(MIPS),Department of Radiology,Stanford Cancer Institute,Bio-X Program,Canary Center at Stanford for Cancer Early Detection,Stanford University
来源：
The Journal of Biomedical Research | 2014年 / 28卷 / 06期
关键词：
PET; molecular probes; personalized medicine;
D O I：
暂无
中图分类号：
R816 [各部位及各科疾病的X线诊断与疗法];
学科分类号：
摘要：
During the past several decades,positron emission tomography(PET) has been one of the rapidly growing areas of medical imaging;particularly,its applications in routine oncological practice have been widely recognized.At present,F-fluorodeoxyglucose(F-FDG) is the most broadly used PET probe.However,F-FDG also suffers many limitations.Thus,scientists and clinicians are greatly interested in exploring and developing new PET imaging probes with high affinity and specificity.In this review,we briefly summarize the representative PET probes beyondF-FDG that are available for patients imaging in three major clinical areas(oncology,neurology and cardiology),and we also discuss the feasibility and trends in developing new PET probes for personalized medicine.
引用
收藏
页码：435 / 446
页数：12
相关论文
共 50 条
  • [41] 18F-FDG PET and Cardiac Metabolic Monitoring
    不详
    JOURNAL OF NUCLEAR MEDICINE, 2013, 54 (05) : 23N - 23N
  • [42] 18F-FDG PET/CT in Bladder Cancer
    Tagliabue, Luca
    Russo, Giovanna
    Lucignani, Giovanni
    CLINICAL NUCLEAR MEDICINE, 2016, 41 (12) : E522 - E524
  • [43] 18F-FDG PET in the management of endometrial cancer
    Chao, A
    Chang, TC
    Ng, KK
    Hsueh, S
    Huang, HJ
    Chou, HH
    Tsai, CS
    Yen, TC
    Wu, TI
    Lai, CH
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 (01) : 36 - 44
  • [44] PET/CT with 18F-FDG in the evaluation of Sarcomas
    Jover-Diaz, R.
    Vicente-Bartulos, A.
    Lourido-Garcia, D.
    Gorospe-Sarasua, L.
    Montero-Navas, A.
    Garcia-Poza, J.
    Ortiz, E.
    Pozo, M.
    Nunez-Miller, R.
    Alfonso-Alfonso, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S444 - S444
  • [45] Evaluation of response: is 18F-FDG PET the answer?
    Chiti, Arturo
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 (05) : 733 - 734
  • [46] 18F-FDG PET/CT in the Management of Aortitis
    Bruls, Samuel
    Courtois, Audrey
    Nusgens, Betty
    Defraigne, Jean-Olivier
    Delvenne, Philippe
    Hustinx, Roland
    Moutschen, Michel
    Sakalihasan, Natzi
    CLINICAL NUCLEAR MEDICINE, 2016, 41 (01) : 28 - 33
  • [47] 18F-FDG PET findings of elastofibroma dorsi
    Koyama, K.
    Okamura, T.
    Hamazawa, Y.
    Seura, H.
    Miki, Y.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S443 - S443
  • [48] Detection of widespread neurolymphomatosis with 18F-FDG PET
    Emel Öztürk
    Fikret Arpaci
    Murat Kocaoğlu
    Nuri Arslan
    Nail Bulakbaşi
    Mehmet Özgüven
    European Journal of Nuclear Medicine and Molecular Imaging, 2006, 33 : 975 - 976
  • [49] Peritoneal carcinomatosis:: Role of 18F-FDG PET
    Turlakow, A
    Yeung, HW
    Salmon, AS
    Macapinlac, HA
    Larson, SM
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (09) : 1407 - 1412
  • [50] Abdominal gossypiboma in PET / CT with 18F-FDG
    Sanchez-Aguilar, Marta
    Javier Garcia-Gomez, Francisco
    Caballero-Gullon, Luis
    IMAGEN DIAGNOSTICA, 2018, 9 (01): : 29 - 30
12345